Overview

Phase 1 Thorough QT Study in Young Healthy Volunteers

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
A reduction in the postoperative need for opioids to enhance the recovery process and increase patient postoperative satisfaction.
Phase:
Phase 1
Details
Lead Sponsor:
Pacira Pharmaceuticals, Inc
Collaborator:
Richmond Pharmacology Limited
Treatments:
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination